These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Enhancing Antifungal Treatment of Sato MR; Oshiro-Junior JA; Rodero CF; Boni FI; Araújo VHS; Bauab TM; Nicholas D; Callan JF; Chorilli M Pharmaceuticals (Basel); 2023 Aug; 16(8):. PubMed ID: 37631009 [TBL] [Abstract][Full Text] [Related]
3. Photodynamic potential of hexadecafluoro zinc phthalocyanine in nanostructured lipid carriers: physicochemical characterization, drug delivery and antimicrobial effect against Candida albicans. Santos KLM; Nunes AMA; de Mendonça Y Araujo SED; de Melo DF; de Lima Damasceno BPG; Sato MR; Oshiro-Junior JA Lasers Med Sci; 2022 Oct; 37(8):3183-3191. PubMed ID: 35723829 [TBL] [Abstract][Full Text] [Related]
4. In vivo study of hypericin-loaded poloxamer-based mucoadhesive in situ gelling liquid crystalline precursor system in a mice model of vulvovaginal candidiasis. de Araújo PR; Calixto GMF; Araújo VHS; Sato MR; Rodero CF; Oshiro-Junior JA; Bauab TM; Chorilli M Med Mycol; 2021 Jul; 59(8):821-827. PubMed ID: 33626136 [TBL] [Abstract][Full Text] [Related]
5. Plasma-based strategy for inhibiting Candida albicans growth and CaMCA1 gene expression in vitro and reducing fungal pathogenicity in a murine model of vulvovaginal candidiasis. Ebrahimi-Shaghaghi F; Atyabi SM; Razzaghi-Abyaneh M Med Mycol; 2021 Dec; 60(1):. PubMed ID: 34694384 [TBL] [Abstract][Full Text] [Related]
7. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.]. Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489 [TBL] [Abstract][Full Text] [Related]
8. Curcumin-Loaded Liquid Crystalline Systems for Controlled Drug Release and Improved Treatment of Vulvovaginal Candidiasis. Rodero CF; Fioramonti Calixto GM; Cristina Dos Santos K; Sato MR; Aparecido Dos Santos Ramos M; Miró MS; Rodríguez E; Vigezzi C; Bauab TM; Sotomayor CE; Chorilli M Mol Pharm; 2018 Oct; 15(10):4491-4504. PubMed ID: 30184431 [TBL] [Abstract][Full Text] [Related]
9. In vitro outcomes of quercetin on Candida albicans planktonic and biofilm cells and in vivo effects on vulvovaginal candidiasis. Evidences of its mechanisms of action. Tan Y; Lin Q; Yao J; Zhang G; Peng X; Tian J Phytomedicine; 2023 Jun; 114():154800. PubMed ID: 37043980 [TBL] [Abstract][Full Text] [Related]
10. ROS mediated anticandidal efficacy of 3-Bromopyruvate prevents vulvovaginal candidiasis in mice model. Jothi R; Hong ST; Enkhtsatsral M; Pandian SK; Gowrishankar S PLoS One; 2023; 18(12):e0295922. PubMed ID: 38153954 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates. Waikhom SD; Afeke I; Kwawu GS; Mbroh HK; Osei GY; Louis B; Deku JG; Kasu ES; Mensah P; Agede CY; Dodoo C; Asiamah EA; Tampuori J; Korbuvi J; Opintan JA BMC Pregnancy Childbirth; 2020 May; 20(1):266. PubMed ID: 32375724 [TBL] [Abstract][Full Text] [Related]
12. Pattern of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral fluconazole therapy. Goswami D; Goswami R; Banerjee U; Dadhwal V; Miglani S; Lattif AA; Kochupillai N J Infect; 2006 Feb; 52(2):111-7. PubMed ID: 15908007 [TBL] [Abstract][Full Text] [Related]
13. Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis. Gao M; Wang H; Zhu L Cell Physiol Biochem; 2016; 40(3-4):727-742. PubMed ID: 27915337 [TBL] [Abstract][Full Text] [Related]
14. Improved in vitro and in vivo Anti- Gaspar de Toledo L; Dos Santos Ramos MA; Bento da Silva P; Rodero CF; de Sá Gomes V; Noronha da Silva A; Pavan FR; da Silva IC; Bombarda Oda F; Flumignan DL; Gonzaga Dos Santos A; Chorilli M; Gottardo de Almeida MT; Bauab TM Int J Nanomedicine; 2020; 15():10481-10497. PubMed ID: 33402821 [TBL] [Abstract][Full Text] [Related]
15. Development, optimization, and evaluation of a nanostructured lipid carrier of sesame oil loaded with miconazole for the treatment of oral candidiasis. Hosny KM; Sindi AM; Ali S; Alharbi WS; Hajjaj MS; Bukhary HA; Badr MY; Mushtaq RY; Murshid SSA; Almehmady AM; Bakhaidar RB; Alfayez E; Kurakula M Drug Deliv; 2022 Dec; 29(1):254-262. PubMed ID: 35014929 [No Abstract] [Full Text] [Related]
16. Photodynamic fungicidal efficacy of hypericin and dimethyl methylene blue against azole-resistant Candida albicans strains. Paz-Cristobal MP; Royo D; Rezusta A; Andrés-Ciriano E; Alejandre MC; Meis JF; Revillo MJ; Aspiroz C; Nonell S; Gilaberte Y Mycoses; 2014 Jan; 57(1):35-42. PubMed ID: 23905682 [TBL] [Abstract][Full Text] [Related]
17. Antifungal activity of cathelicidin peptides against planktonic and biofilm cultures of Candida species isolated from vaginal infections. Scarsini M; Tomasinsig L; Arzese A; D'Este F; Oro D; Skerlavaj B Peptides; 2015 Sep; 71():211-21. PubMed ID: 26238597 [TBL] [Abstract][Full Text] [Related]
18. p-Coumaric acid loaded into liquid crystalline systems as a novel strategy to the treatment of vulvovaginal candidiasis. Ferreira PS; Victorelli FD; Rodero CF; Fortunato GC; Araújo VHS; Fonseca-Santos B; Bauab TM; Van Dijck P; Chorilli M Int J Pharm; 2021 Jun; 603():120658. PubMed ID: 33964336 [TBL] [Abstract][Full Text] [Related]
19. Phytolectin nanoconjugates in combination with standard antifungals curb multi-species biofilms and virulence of vulvovaginal candidiasis (VVC) causing Candida albicans and non-albicans Candida. Senthilganesh J; Kuppusamy S; Durairajan R; Subramaniyan SB; Veerappan A; Paramasivam N Med Mycol; 2022 Jan; 60(2):. PubMed ID: 34958385 [TBL] [Abstract][Full Text] [Related]